What does Dokter Julie Roobroeck do?

Dokter Julie Roobroeck is a general practice in Dendermonde. Private Limited, started on 5 January 2021, 1 establishment.

What is the address of Dokter Julie Roobroeck?

The registered office of Dokter Julie Roobroeck is located at Steenweg van Grembergen 37, 9200 Dendermonde.

Is Dokter Julie Roobroeck still active?

Yes. According to the CBE (30 September 2026) Dokter Julie Roobroeck is active, legal situation “Normale toestand”, started on 5 January 2021.

Is Dokter Julie Roobroeck registered on Peppol?

Yes, Dokter Julie Roobroeck is registered on the Peppol network with ID 0208:0760821379.

What is the enterprise number of Dokter Julie Roobroeck?

The enterprise number of Dokter Julie Roobroeck is BE0760821379.

When was Dokter Julie Roobroeck founded?

Dokter Julie Roobroeck was founded on 5 January 2021.

Who are the directors of Dokter Julie Roobroeck?

According to the 2025 annual accounts, the directors of Dokter Julie Roobroeck are: Julie Roobroeck.

Is Dokter Julie Roobroeck a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 January 2021; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dokter Julie Roobroeck make in 2025?

Dokter Julie Roobroeck posted a profit after taxes of € 88,327 in financial year 2025.

What is the revenue of Dokter Julie Roobroeck?

As a small company, Dokter Julie Roobroeck is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 131,498.

Dokter Julie Roobroeck (Private Limited) - Dendermonde

Dossier Dokter Julie Roobroeck, printed on 30 September 2026 from databakkes.be/en/0760821379/dokter-julie-roobroeck. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dokter Julie Roobroeck from Dendermonde, company number BE0760821379, closed financial year 2025 with a result of € 88,327 after tax. For that financial year Dokter Julie Roobroeck recorded a gross margin of € 131,498 and equity of € 8,494. Compared with financial year 2024, the result moved from € 81,944 to € 88,327. Profitable, and profit is growing. The buffer shrank hard: equity is 88 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Shrank hard

€ 8,494

▼ 88% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 88,327

▲ 8% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 165,675

▲ 20% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 152,777 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 2,264

▼ 81% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 148,000

▲ 104% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 9

▼ 78% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 25,065

▲ € 19,865 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 54,671 Gross margin 2022: € 54,671 First fiscal year in the series	€ 39,455 Gross margin 2023: € 39,455 ▼ 28% vs 2022 (€ 54,671) Unfavourable step	€ 113,298 Gross margin 2024: € 113,298 ▲ 187% vs 2023 (€ 39,455) Favourable step	€ 131,498 Gross margin 2025: € 131,498 ▲ 16% vs 2024 (€ 113,298) Favourable step	▲ 16%
Profit after taxes	€ 42,167 Profit after taxes 2022: € 42,167 First fiscal year in the series	€ 33,737 Profit after taxes 2023: € 33,737 ▼ 20% vs 2022 (€ 42,167) Unfavourable step	€ 81,944 Profit after taxes 2024: € 81,944 ▲ 143% vs 2023 (€ 33,737) Favourable step	€ 88,327 Profit after taxes 2025: € 88,327 ▲ 8% vs 2024 (€ 81,944) Favourable step	▲ 8%
Equity	€ 107,019 Equity 2022: € 107,019 First fiscal year in the series	€ 119,923 Equity 2023: € 119,923 ▲ 12% vs 2022 (€ 107,019) Favourable step	€ 72,944 Equity 2024: € 72,944 ▼ 39% vs 2023 (€ 119,923) Unfavourable step	€ 8,494 Equity 2025: € 8,494 ▼ 88% vs 2024 (€ 72,944) Unfavourable step	▼ 88%
Total debts	€ 15,110 Total debts 2022: € 15,110 First fiscal year in the series	€ 16,266 Total debts 2023: € 16,266 ▲ 8% vs 2022 (€ 15,110) Unfavourable step	€ 77,740 Total debts 2024: € 77,740 ▲ € 61,473 vs 2023 (€ 16,266) Unfavourable step	€ 173,268 Total debts 2025: € 173,268 ▲ 123% vs 2024 (€ 77,740) Unfavourable step	▲ 123%
Cash	€ 120,052 Cash 2022: € 120,052 First fiscal year in the series	€ 134,645 Cash 2023: € 134,645 ▲ 12% vs 2022 (€ 120,052) Favourable step	€ 137,907 Cash 2024: € 137,907 ▲ 2% vs 2023 (€ 134,645) Favourable step	€ 165,675 Cash 2025: € 165,675 ▲ 20% vs 2024 (€ 137,907) Favourable step	▲ 20%
Retained profit	€ 106,019 Retained profit 2022: € 106,019 First fiscal year in the series	€ 118,923 Retained profit 2023: € 118,923 ▲ 12% vs 2022 (€ 106,019) Favourable step	€ 71,944 Retained profit 2024: € 71,944 ▼ 40% vs 2023 (€ 118,923) Unfavourable step	€ 7,494 Retained profit 2025: € 7,494 ▼ 90% vs 2024 (€ 71,944) Unfavourable step	▼ 90%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 20,833 Dividend 2023: € 20,833 ▲ € 20,033 vs 2022 (€ 800) Unchanged	€ 128,923 Dividend 2024: € 128,923 ▲ € 108,090 vs 2023 (€ 20,833) Unchanged	€ 152,777 Dividend 2025: € 152,777 ▲ 19% vs 2024 (€ 128,923) Unchanged	▲ 19%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 72,500 Bank debt 2024: € 72,500 Unchanged (€ 0) Unfavourable step	€ 148,000 Bank debt 2025: € 148,000 ▲ 104% vs 2024 (€ 72,500) Unfavourable step	▲ 104%
Balance sheet total	€ 122,129 Balance sheet total 2022: € 122,129 First fiscal year in the series	€ 136,190 Balance sheet total 2023: € 136,190 ▲ 12% vs 2022 (€ 122,129) Unchanged	€ 150,684 Balance sheet total 2024: € 150,684 ▲ 11% vs 2023 (€ 136,190) Unchanged	€ 181,762 Balance sheet total 2025: € 181,762 ▲ 21% vs 2024 (€ 150,684) Unchanged	▲ 21%

Key figures of Dokter Julie Roobroeck, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dokter Julie Roobroeck?

What happened at Dokter Julie Roobroeck in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: profit of € 88,327 (▲ 8% vs 2024). Source: NBB ↗
Jan 5, 2021 New establishment in Dendermonde. KBO
Jan 5, 2021 Start of the company according to the CBE. KBO

In short

From € 42,167 profit in 2022 to € 88,327 profit in 2025.

Paid € 61,264 in corporate taxes since 2022.

Best year ever: 2025, with € 88,327 profit.

Paid out € 303,333 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dokter Julie Roobroeck? We notify you, reason included.

Follow Dokter Julie Roobroeck

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Julie Roobroeck

Dokter Julie Roobroeck

LOMEER INVEST

Behind Dokter Julie Roobroeck is Julie Roobroeck. Julie Roobroeck is also behind LOMEER INVEST.

See the full network in the app

Directors

According to the 2025 annual accounts

Julie Roobroeck

Director

Also active at: LOMEER INVEST

Establishments

Establishment units

Physical locations of this company

Registered office

Steenweg van Grembergen 37

9200 Dendermonde

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0760.821.379
VAT number: BE 0760.821.379
Registered office: Steenweg van Grembergen 37, 9200 Dendermonde
Names & denominations: Dokter Julie Roobroeck
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 5 January 2021
Peppol: Active · Active since 27 Nov 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗